Longevity genetics examines genetic variants associated with aging and lifespan. Research has identified candidate genes (e.g., APOE, FOXO3, SIRT1), but their individual effects are small, explaining only a minor fraction of lifespan variation. Direct-to-consumer (DTC) tests often market 'longevity' panels, but clinical validity is weak: effect sizes are modest, and lifestyle factors (diet, exercise, smoking) have far greater impact. The provided context does not contain specific longevity genes; the mentioned MMP1 gene encodes a matrix metalloproteinase linked to skin aging and connective tissue breakdown, not directly to lifespan. Conclusion: Longevity genetics is an emerging field with limited actionable evidence. Consumers should be cautious of exaggerated claims and not interpret results as medical diagnoses or prognoses.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-13595e04cb38c8394532c5fe